CEO David Joyner highlighted the company's Q4 adjusted EPS of $1.19 and adjusted operating income of $2.7 billion. He introduced 2025 adjusted EPS guidance of $5.75 to $6.00, emphasizing recovery ...
Looking ahead, CVS Health's management forecasts an adjusted EPS range of $5.75 to $6.00 for 2025, expecting enhancements in financial results as value-based initiatives and digital investments ...